Stock TECH BIO-TECHNE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Bio-Techne Corporation

Equities

TECH

US09073M1045

Real-time Estimate Cboe BZX
Other stock markets
 13:14:01 2024-04-29 EDT 		5-day change 1st Jan Change
65.22 USD +1.81% Intraday chart for Bio-Techne Corporation +4.58% -14.88%
04:39pm Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific MT
03:40pm RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79 MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific
MT
RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79
MT
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
PR
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific
CI
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
PR
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay
CI
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe
MT
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
PR
Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85
MT
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
PR
RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating
MT
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
PR
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
PR
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says
MT
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
PR
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
AQ
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia
MT
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
PR
Transcript : Bio-Techne Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:45 AM
Transcript : Bio-Techne Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TECH Stock
  4. News Bio-Techne Corporation